ALANNA CELLINI: Open Payments
NPI 1982000238 · BUTLER, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$218 in 12 payments from 10 companies in 2025. Trend: 2023 $228 · 2024 $126 · 2025 $218
Food & beverage: $218
| Company | Payments | Amount |
|---|---|---|
| Astellas Pharma US Inc | 2 | $40 |
| Exeltis, USA Inc. | 2 | $37 |
| Abbott Laboratories | 1 | $21 |
| Novo Nordisk Inc | 1 | $19 |
| PFIZER INC. | 1 | $19 |
| Amgen Inc. | 1 | $19 |
| Organon LLC | 1 | $17 |
| Lilly USA, LLC | 1 | $17 |
| Sage Therapeutics, LLC | 1 | $14 |
| MAYNE PHARMA COMMERCIAL LLC | 1 | $14 |
Products named: Veozah, SLYND, AVEIR, Wegovy, ABRYSVO, EVENITY, JADA SYSTEM, ZEPBOUND.
Industry payments across PA — which companies pay providers there.
